Terms: = Ovarian cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
28 results:
1. Early ovarian cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review.
Greenwood A; Woodruff ER; Nguyen C; Piper C; Clauset A; Brubaker LW; Behbakht K; Bitler BG
Obstet Gynecol; 2024 Mar; 143(3):e63-e77. PubMed ID: 38176019
[TBL] [Abstract] [Full Text] [Related]
2. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
Yao H; Li N; Yuan H
BMC Cancer; 2022 Dec; 22(1):1337. PubMed ID: 36544182
[TBL] [Abstract] [Full Text] [Related]
4. Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission.
Smaletz O; Ismael G; Del Pilar Estevez-Diz M; Nascimento ILO; de Morais ALG; Cunha-Junior GF; Azevedo SJ; Alves VA; Moro AM; Yeda FP; Dos Santos ML; Majumder I; Hoffman EW
Int J Gynecol Cancer; 2021 Apr; 31(4):562-568. PubMed ID: 33664128
[TBL] [Abstract] [Full Text] [Related]
5. A multicentre clinical validation of AminoIndex cancer Screening (AICS).
Mikami H; Kimura O; Yamamoto H; Kikuchi S; Nakamura Y; Ando T; Yamakado M
Sci Rep; 2019 Sep; 9(1):13831. PubMed ID: 31554861
[TBL] [Abstract] [Full Text] [Related]
6. Cigarette smoking and the association with serous ovarian cancer in African American women: African American cancer Epidemiology Study (AACES).
Kelemen LE; Abbott S; Qin B; Peres LC; Moorman PG; Wallace K; Bandera EV; Barnholtz-Sloan JS; Bondy M; Cartmell K; Cote ML; Funkhouser E; Paddock LE; Peters ES; Schwartz AG; Terry P; Alberg AJ; Schildkraut JM
Cancer Causes Control; 2017 Jul; 28(7):699-708. PubMed ID: 28466107
[TBL] [Abstract] [Full Text] [Related]
7. The clinical significance of vascular endothelial growth factor in malignant ascites.
Zhan N; Dong WG; Wang J
Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
[TBL] [Abstract] [Full Text] [Related]
8. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of plasma lysophosphatidic acid levels in the differential diagnosis of ovarian cancer.
Zhang YJ; Cao LY; Fu ZZ; Wang YJ; Wang GX; Gu T
J Cancer Res Ther; 2015; 11(2):375-80. PubMed ID: 26148603
[TBL] [Abstract] [Full Text] [Related]
10. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract] [Full Text] [Related]
11. Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.
Charpentier AM; Chong AL; Gingras-Hill G; Ahmed S; Cigsar C; Gupta AA; Greenblatt E; Hodgson DC
J Cancer Surviv; 2014 Dec; 8(4):548-54. PubMed ID: 24810980
[TBL] [Abstract] [Full Text] [Related]
12. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
[TBL] [Abstract] [Full Text] [Related]
13. Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry.
Amiot C; Angelot-Delettre F; Zver T; Alvergnas-Vieille M; Saas P; Garnache-Ottou F; Roux C
Hum Reprod; 2013 Aug; 28(8):2157-67. PubMed ID: 23633552
[TBL] [Abstract] [Full Text] [Related]
14. Malignant Brenner tumor of the ovary: analysis of 13 cases.
Gezginç K; Karatayli R; Yazici F; Acar A; Çelik Ç; Çapar M; Tavli L
Int J Clin Oncol; 2012 Aug; 17(4):324-9. PubMed ID: 21796330
[TBL] [Abstract] [Full Text] [Related]
15. ovarian pathology for the pediatric urologist.
Yiee JH; Betts J; Baskin LS
Urology; 2011 Jun; 77(6):1455-9. PubMed ID: 21256573
[TBL] [Abstract] [Full Text] [Related]
16. Time costs associated with informal caregiving for cancer survivors.
Yabroff KR; Kim Y
Cancer; 2009 Sep; 115(18 Suppl):4362-73. PubMed ID: 19731345
[TBL] [Abstract] [Full Text] [Related]
17. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT
Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705
[TBL] [Abstract] [Full Text] [Related]
18. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract] [Full Text] [Related]
19. Characterization of serum biomarkers for detection of early stage ovarian cancer.
Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R
Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736
[TBL] [Abstract] [Full Text] [Related]
20. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract] [Full Text] [Related]
[Next]
